Moreover, Koivunen et al. (2012) suggested that, in IDH-mutant gliomas, D-2HG increases the activity of prolyl hydroxylase domain protein 2 (encoded by EGLN1), which subsequently decreases HIF activity [11] (Fig 1). The gene discussed is IDH1; the disease is central nervous system cancer.